Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer

Clinical trial NCT05794659 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05794659
Sponsor: Aston Sci. Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Ovarian Cancer

Start date: 2023-11-15
Primary completion: 2025-11-15
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.